Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), L. Lahousse (Ghent, Belgium), P. De Nocker (Ghent, Belgium), B. Stricker (Rotterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study. 5233

Member's Comments

No comment yet.

Related content which might interest you: Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 Prevalence and incidence of COPD: The Rotterdam study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study Source: International Congress 2019 – Genes and environment Year: 2019 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 The lifetime risk of developing COPD. The Rotterdam study Source: Annual Congress 2008 - Environmental risk factors for respiratory symptoms and COPD Year: 2008 Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Factors associated with COPD exacerbation frequency in a UK primary care cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort Source: Virtual Congress 2021 – Environment and respiratory health Year: 2021 The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 The Rotterdam study: why fall in COPD? Source: Eur Respir J 2015; 46: 1529-1530 Year: 2015 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The Rotterdam study: why fall in COPD? Source: Eur Respir J 2015; 46: 1530-1531 Year: 2015